Literature DB >> 15198194

Recurrent tendinitis after treatment with two different fluoroquinolones.

Olaf Burkhardt1, Thomas Köhnlein, Thomas Pap, Tobias Welte.   

Abstract

Tendinopathies with and without tendon rupture are rare adverse events, occurring mainly following older fluoroquinolones, but recently also to an increasing extent following levofloxacin. We report the first case of tendinitis after treatment with moxifloxacin, and of recurrent tendinitis after treatment with 2 different fluoroquinolones. From these findings we conclude hitherto unexplained class effect of fluoroquinolones in respect of the development of tendinitis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15198194     DOI: 10.1080/00365540410019390

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  10 in total

1.  Fluoroquinolone-induced serious, persistent, multisymptom adverse effects.

Authors:  Beatrice Alexandra Golomb; Hayley Jean Koslik; Alan J Redd
Journal:  BMJ Case Rep       Date:  2015-10-05

Review 2.  Safety profile of the fluoroquinolones: focus on levofloxacin.

Authors:  Hans H Liu
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

Review 3.  Tendon Injury and Fluoroquinolone Use: A Systematic Review.

Authors:  Anne L Stephenson; Wei Wu; Daniel Cortes; Paula A Rochon
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

Review 4.  A typical presentation of moxifloxacin-induced DRESS syndrome with pulmonary involvement: a case report and review of the literature.

Authors:  Yinhong Zhang; Xiaoyan Wang; Yang Cheng; Xiaofang Wang; Yunjian Zhang
Journal:  BMC Pulm Med       Date:  2022-07-19       Impact factor: 3.320

5.  Levofloxacin-induced Achilles tendinitis in a young adult in the absence of predisposing conditions.

Authors:  Areum Durey; Yong Soo Baek; Jin Seok Park; Kwangsoo Lee; Jeong-Seon Ryu; Jin-Soo Lee; Moon-Hyun Cheong
Journal:  Yonsei Med J       Date:  2010-05       Impact factor: 2.759

Review 6.  Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes.

Authors:  Françoise Van Bambeke; Paul M Tulkens
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

7.  Spontaneous bilateral Achilles tendon rupture in a patient treated with oral levofloxacin.

Authors:  A E Salvi; G P Metelli; A Bosco; A Berizzi; S A Hacking; A Cantalamessa
Journal:  J Orthop Traumatol       Date:  2007-06-08

Review 8.  The Possible Role of Helicobacter pylori in Gastric Cancer and Its Management.

Authors:  Khalid O Alfarouk; Adil H H Bashir; Ahmed N Aljarbou; AbdelRahman M Ramadan; Abdel Khalig Muddathir; Sari T S AlHoufie; Abdelhamid Hifny; Gamal O Elhassan; Muntaser E Ibrahim; Saad S Alqahtani; Shakir D AlSharari; Claudiu T Supuran; Cyril Rauch; Rosa Angela Cardone; Stephan J Reshkin; Stefano Fais; Salvador Harguindey
Journal:  Front Oncol       Date:  2019-02-22       Impact factor: 6.244

Review 9.  A brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP).

Authors:  Anna M Ferrara
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

10.  Skin and soft tissue infection by Mycobacterium intracellulare in an immunocompetent patient.

Authors:  Alessio Pampaloni; Salvatore Tosto; Maria Elena Locatelli; Adele Gentile; Daniele Scuderi; Andrea Marino; Federica Cosentino; Vittoria Moscatt; Giuseppe Nunnari; Bruno Cacopardo
Journal:  IDCases       Date:  2020-02-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.